Nodal T-Follicular Helper Cell Lymphoma, Angioimmunoblastic-Type, Diagnosed in a Patient with Psoriasis Following COVID-19 Vaccination under Adalimumab Treatment: A Causal Association?

The article presents a case study of a patient with psoriasis who developed nodal T-follicular helper cell lymphoma, angioimmunoblastic-type, following COVID-19 vaccination while on adalimumab treatment. Topics discussed include the potential association between adalimumab and lymphoma risk, the impact of messenger ribonucleic acid (mRNA) COVID-19 vaccines on lymphoproliferative disorders, and the role of Epstein-Barr virus reactivation in lymphomagenesis.